1307 |
RIKS HIA Survival benefits by 12 years registry supported improvement of acute cardiac care in the Sweden - the RIKS-HIA 12 years study |
|
Oct. 18. 10 |
1306 |
Remote preconditioning reflex - a neural pathway of cardioprotection during myocardial ischaemia and reperfusion induced by remote ischaemic preconditioning |
|
Oct. 18. 10 |
1305 |
PLATO genetic substudy Impact of CYP2C19 and ABCB1 single nucleotide polymorphisms (SNPs) on outcomes with ticagrelor and clopidogrel in ACS - a PLATO genetic substudy |
|
Oct. 18. 10 |
1304 |
MULTI STRATEGY 3-year F-U of the Comparison of Angioplasty with Tirofiban or Abciximab and with Implantation of Sirolimus-Eluting or Uncoated Stents for AMI |
|
Oct. 18. 10 |
1303 |
LESSON I Long-term comparison of Everolimus-eluting and Sirolimus-eluting Stents for coronary revascularization |
|
Oct. 18. 10 |
1302 |
ISAR TEST 4 Two-year Clinical Outcomes from a Randomized Trial of Biodegradable Polymer Drug-Eluting Stents Versus Permanent Polymer Cypher and Xience Drug-Eluting Stents |
|
Oct. 18. 10 |
1301 |
ISAR REACT 3A A trial of reduced dose of unfractionated heparin in patients undergoing percutaneous coronary interventions |
|
Oct. 18. 10 |
1300 |
INNOVATE PCI A Phase II Safety and Efficacy Study of PRT060128 (Elinogrel), a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI. |
|
Oct. 18. 10 |
1299 |
HEBE III A single dose of erythropoietin in ST-elevation myocardial infarction |
|
Oct. 18. 10 |
1298 |
GRACE Five year outcomes (UK Belgian collaboration) |
|
Oct. 18. 10 |